Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Topics : Protheses and implants
Topics : Disability
Active substance : atropine
Active substance : ceftazidime

Topic

Diagnostic and therapeutic techniques (1)
Plus ...
- Protheses and implants (1)
Diseases and conditions (1)
Plus ...

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

inconnu (1)

Français (1)

Active substance

atropine (1)
ceftazidime (1)
morphine (1)
prednisolone (1)
vancomycine (1)

Drugs, devices and medical acts - 1 result

Assessment of an epiretinal implant and its implantation procedure

Health technology assessment - Posted on 20/12/2012

Download document

Add to my selection

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

57q1tm20aZ2eUSjS